Whoever it chooses will have to make some incredibly bold decisions if they are to correct the faults of their two predecessors — and I strongly suspect that they won't.
Despite the hit to its share price, Apotheker's decision is the sort of incrediblybold and honest move that is rarely seen in the world of technology — and it should be applauded.